Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Neil J. Cisper"'
Autor:
Niranjan Y. Sardesai, Colleen E. Lucke, Neil J. Cisper, Amir S. Khan, Lindsey Philipson-Weiner, Kendra T. Talbott, Bernadette Ferraro, David B. Weiner
Publikováno v:
Human Vaccines. 7:120-127
Prostate cancer (PCa) remains a significant public health problem. Current treatment modalities for PCa can be useful, but may be accompanied by deleterious side effects and often do not confer long-term control. Accordingly, additional modalities, s
Autor:
Kimberly A. Kraynyak, Jian Yan, Michele A. Kutzler, David B. Weiner, Ruxandra Draghia-Akli, Mark G. Lewis, Niranjan Y. Sardesal, Amir S. Khan, Neil J. Cisper
Publikováno v:
Vaccine. 28:1942-1951
Plasmid DNA is a promising vaccine platform that has been shown to be safe and able to be administered repeatedly without vector interference. Enhancing the potency of DNA vaccination through co-delivery of molecular adjuvants is one strategy current
Autor:
David B. Weiner, Nyamekye Obeng-Adjei, A. J. Birkett, W. Cabrera, Amir S. Khan, Matthrew P. Morrow, Devon J. Shedlock, Ami Shah Brown, A. K. K. Kayatani, A. Balakrishnan, N. Richie, R. Shiver, Jian Yan, Bernadette Ferraro, Devin J.F. Myles, Neil J. Cisper, Niranjan Y. Sardesai, Kendra T. Talbott, M. Yang, U. Wille-Reece, Natalie A. Hutnick
A vaccine candidate that elicits humoral and cellular responses to multiple sporozoite and liver-stage antigens may be able to confer protection against Plasmodium falciparum malaria; however, a technology for formulating and delivering such a vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dfe604d8efa4cda4ff9b9054cfeaba3
https://europepmc.org/articles/PMC3811783/
https://europepmc.org/articles/PMC3811783/
Autor:
Niranjan Y. Sardesai, Matthew P. Morrow, Christina Cress, David B. Weiner, Steven Tuyishme, Amir S. Khan, Karuppiah Muthumani, Omkar U. Kawalekar, Devon J. Shedlock, Bernadette Ferraro, Karthik Mallilankaraman, Kendra T. Talbott, Neil J. Cisper, Hao Shen, Stephan J. Wu
Protection against infection is the hallmark of immunity and the basis of effective vaccination. For a variety of reasons there is a great demand to develop new, safer and more effective vaccine platforms. In this regard, while ‘first-generation’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8578c20a53cd1b923755e01b56bcb05
https://europepmc.org/articles/PMC3167034/
https://europepmc.org/articles/PMC3167034/
Autor:
Kimberly A. Kraynyak, Dominick Laddy, Thomas A. Waldmann, Michele A. Kutzler, Neil J. Cisper, Matthew P. Morrow, David B. Weiner
Publikováno v:
Human gene therapy. 20(10)
Plasmid-encoded DNA vaccines appear to be a safe and effective method for delivering antigen; however, the immunogenicity of such vaccines is often suboptimal. Cytokine adjuvants including interleukin (IL)-12, RANTES, granulocyte-macrophage colony-st
Autor:
Panyupa Pankhong, Dominick Laddy, David B. Weiner, Jian Yan, Kimberly A. Schoenly, Matthew P. Morrow, Neil J. Cisper
Publikováno v:
Blood. 113(23)
Improving the potency of immune responses is paramount among issues concerning vaccines against deadly pathogens. IL-28B belongs to the newly described interferon lambda (IFNλ) family of cytokines, and has not yet been assessed for its potential abi
Autor:
Kimberly Ann Schoenly, Michele A Kutzler, Neil J Cisper, Jian Yan, Amir S Khan, Ruxandra Draghia-Akli, Mark G Lewis, David B Weiner
Publikováno v:
The Journal of Immunology. 182:39.51-39.51
As the primary site of HIV-1 replication is the mucosa, a desirable feature of a HIV-1 vaccine would be the generation of immune responses at mucosal sites. We created an optimized CCL27 DNA construct as well as optimized SIV gag, pol, and env plasmi
Autor:
Kimberly A. Kraynyak, Michele A. Kutzler, Neil J. Cisper, Dominick J. Laddy, Matthew P. Morrow, Thomas A. Waldmann, David B. Weiner
Publikováno v:
Human Gene Therapy; Oct2009, Vol. 20 Issue 10, p1143-1156, 14p